2m 2m 2m 2m 2m 2m 2m
CARTESIAN (RNAC)
NASDAQ
$6.38-$0.03 (-0.45%)
Price as of Jun 03, 2026 6:01 PM EDT- $221.5MMarket Cap
- -35.25%1-Year Change
- BiotechnologyIndustry
CARTESIAN (RNAC)
$6.38-$0.03 (-0.45%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.8M -92.81% | 38.9M +49.64% | 26.0M -76.53% | 110.8M +30.21% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 2.8M -92.81% | 38.9M +49.64% | 26.0M -76.53% | 110.8M +30.21% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -58.0M +28.66% | -45.1M -37.21% | -71.8M -0.74% | -72.4M +5.30% | |
Depreciation and Amortization Expense | 3.0M +157.08% | 1.2M +36.54% | 843,000 -34.50% | 1.3M +2.80% | |
Total Operating Expenses | 146.2M +76.55% | 82.8M -26.34% | 112.4M +16.81% | 96.2M +7.32% | |
Operating Profit | -143.4M +226.69% | -43.9M -49.20% | -86.4M -694.41% | 14.5M +416.25% | |
Interest Income | 6.6M -10.93% | 7.4M N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | 0 +100.00% | -2.8M -6.53% | -3.0M +6.58% | |
Interest Income and Expense and Net | 6.6M -10.93% | 7.4M +360.71% | -2.8M -6.53% | -3.0M +6.58% | |
Total Nonoperating Income and Expense | 3.9M +545.21% | 606,000 -12.30% | 691,000 +109.39% | 330,000 +2,100.00% | |
Income before Taxes | -139.5M +80.84% | -77.1M -67.69% | -238.7M -786.54% | 34.8M +457.68% | |
Income Taxes | -9.2M -3,303.14% | 287,000 +101.51% | -19.0M +3,019.87% | -609,000 -103.81% | |
Extraordinary Items | 7.6M +0.28% | 7.6M N/A | N/A N/A | N/A N/A | |
Net Income | -130.3M +68.30% | -77.4M -64.76% | -219.7M -721.02% | 35.4M +237.73% | |
Net Income from Continuing Operations Applicable to Common | -139.5M +80.84% | -77.1M -67.69% | -238.7M -786.54% | 34.8M +457.68% | |
Basic EPS and Net Income | -5.02 +12.05% | -4.48 +169.88% | -1.66 -791.67% | 0.24 +209.09% | |
Diluted EPS and Net Income | -5.02 +11.80% | -4.49 +170.48% | -1.66 -1,760.00% | 0.10 +145.45% | |
Basic Weighted Average Shares | 26.0M +50.34% | 17.3M -88.86% | 155.1M +7.15% | 144.8M +26.62% | |
Diluted Weighted Average Shares | 26.0M +49.63% | 17.4M -88.81% | 155.1M +6.33% | 145.9M +27.59% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 125.1M -41.14% | 212.6M +176.44% | 76.9M -27.74% | 106.4M -6.68% | |
Short-Term Investments | N/A N/A | N/A N/A | 0 -100.00% | 28.2M +101.20% | |
Cash and Cash Equivalents and Short-Term Investments | 125.1M -41.14% | 212.6M +176.44% | 76.9M -42.86% | 134.6M +5.11% | |
Total Current Assets | 129.3M -40.32% | 216.6M +138.76% | 90.7M -38.75% | 148.1M +2.56% | |
Accumulated Depreciation | 4.7M +100.81% | 2.4M -58.85% | 5.7M +10.05% | 5.2M +8.51% | |
Property and Plant and Equipment and Net | 12.2M +22.93% | 9.9M +369.10% | 2.1M -24.37% | 2.8M +30.44% | |
Total Long-Term Assets | 12.2M +2,252.32% | 518,000 N/A | 0 -100.00% | 26,000 -71.11% | |
Total Assets | 296.4M -31.86% | 435.0M +42.61% | 305.1M +83.89% | 165.9M +3.75% | |
Income Taxes Payable | 6.9M -56.95% | 16.1M +1.82% | 15.9M N/A | 0 -100.00% | |
Total Short-Term Debt | N/A N/A | 0 N/A | 0 -100.00% | 8.5M +42.19% | |
Total Current Liabilities | 14.9M -34.99% | 23.0M -66.32% | 68.2M +172.00% | 25.1M -65.29% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 0 -100.00% | 17.8M -9.59% | |
Total Long-Term Liabilities | 22.4M -48.36% | 43.4M -1.40% | 44.0M +50.82% | 29.2M -35.75% | |
Total Liabilities | 422.7M -4.34% | 441.8M -0.64% | 444.7M +517.11% | 72.1M -47.54% | |
Retained Earnings | -822.4M +18.83% | -692.1M +12.60% | -614.6M +55.63% | -394.9M -8.22% | |
Total Stockholders Equity | -126.2M +1,755.92% | -6.8M -98.45% | -440.2M -569.14% | 93.8M +316.62% | |
Total Shares Outstanding | 26.0M +0.95% | 25.8M -84.09% | 161.9M +5.81% | 153.0M +23.80% | |
Cash Flow | |||||
Cash from Operating Activities | -73.9M +212.33% | -23.7M -53.73% | -51.2M +61.74% | -31.6M -47.62% | |
Capital Expenditures | 5.5M -40.02% | 9.1M +4,314.08% | 206,000 -82.85% | 1.2M +10.69% | |
Cash from Investing Activities | -5.5M -37.61% | -8.7M -125.26% | 34.6M +330.70% | -15.0M -12.47% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -8.1M -104.78% | 168.4M +1,381.31% | -13.1M -133.52% | 39.2M -25.87% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -5,127.10% +4,444.98% | -112.81% -66.05% | -332.32% -2,632.20% | 13.12% +342.88% | |
Return on Assets | -35.63% +70.28% | -20.92% -77.58% | -93.31% -529.59% | 21.72% +237.54% | |
Return on Equity | 195.88% +465.43% | 34.64% -72.69% | 126.87% +108.61% | 60.82% +105.34% | |
Revenue Growth | -92.81% -286.96% | 49.64% +164.87% | -76.53% -353.33% | 30.21% -92.68% | |
Current Ratio | 8.65 -8.21% | 9.43 +608.80% | 1.33 -77.48% | 5.91 +195.48% | |
Cash Ratio | 8.38 -9.46% | 9.25 +720.65% | 1.13 -73.43% | 4.24 +168.87% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.00 -100.00% | 0.28 -75.41% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.00 -100.00% | 0.16 -1.25% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow